Richard D. Nanula was appointed chief financial officer of Amgen Inc. in August 2001 and served as executive vice president starting May 2001. He resigned in 2007 amid an SEC inquiry as to why company executives did not immediately disclose negative findings from drug trials. Nanula has also worked with Boeing and Miramax.
[ - ]

Richard D. Nanula was appointed chief financial officer of Amgen Inc. in August 2001 and served...
[ + ]

Richard D. Nanula was appointed chief financial officer of Amgen Inc. in August 2001 and served as executive vice president starting May 2001. He resigned in 2007 amid an SEC inquiry as to why company executives did not immediately disclose negative findings from drug trials. Nanula has also worked with Boeing and Miramax.